About ReNeuron

Partnering

 Patents Read more

Latest News

View all

Corporate Update and Cancellation of Admission to Trading on AIM

Corporate Update and Suspension of Trading on AIM

Interim Results for the six months ended 30 September 2023

ReNeuron presents in vivo data at Cell 2023

R&D Update

Exosomes

 Read more

iPSC

 CTX cells for Critical Limb Ischaemia Read more

Investor Centre

 Investor Centre banner image Read more

The information collected will be used to send you the information you have requested and to provide information that may be useful to you. ReNeuron may share non-personal aggregate statistics (group) data about ReNeuron’s website visitors with partners or other parties. However, ReNeuron will not sell or share any information about individual users. Please ensure you have read the full contents of our Privacy Notice before continuing. If you agree to your information being used in this way, please tick the box: